I give the management some benefit of the doubt as I think they have built value in APNO over the past few years with a very constrictive capital situation, operating with limited cash - that said, I'm not sure they will utimately maximize shareholder value as they could dilute us more vs. selling the Company (if possible) - also, at some point the expense of keeping APNO public makes no sense and there's a fair amount of M@A in life sciences - but management has definitely decided shareholder communication is a waste of time...